Pyrrolobenzodiazepines

Abstract

Compounds of the formula: (I) or solvate thereof, wherein: R2 is an optionally substituted C5-20 aryl group; R6 and R9 are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR', nitro, Me3Sn and halo; where R and R' are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR', nitro, Me3Sn and halo; R'' is a C3-12 alkylene group, which chain may be interrupted by one or more heteroatoms and/or aromatic rings; X is selected from O, S, or NH; z is 2 or 3; M is a monovalent pharmaceutically acceptable cation; R2', R6', R7', R9', X' and M' are selected from the same groups as R2, R6, R7, R9, X and M respectively, or M and M' may together represent a divalent pharmaceutically acceptable cation.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 3, 2009
  • Application: Apr 21, 2006
    US US 91189006 A
  • Priority: Apr 21, 2006
    GB GB 2006001456 W
  • Priority: Nov 7, 2005
    GB GB 0522746 A
  • Priority: Apr 21, 2005
    GB GB 0508084 A

Download Citation


Sign in to the Lens

Feedback